Comparison of Three Methods to Assess Therapeutic Quality Control of Treatment with Vitamin K Antagonists

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Thrombosis and Haemostasis

• Publication date

  1999-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1055/s-0037-1614372PMID 10544910
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Low-molecular-weight heparin in the treatment of patients with venous thromboembolism.

  1997cited by this paper
• Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group.

  1996cited by this paper
• Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia.

  1995cited by this paper
• Optimal oral anticoagulant therapy in patients with mechanical heart valves.

  1995cited by this paper
• Multicenter evaluation of a new capillary blood prothrombin time monitoring system

  1995cited by this paper
• Assessment of Therapeutic Quality Control in a Long-Term Anticoagulant Trial in Post-Myocardial Infarction Patients

  1994cited by this paper
• Bleeding complications in oral anticoagulant therapy. An analysis of risk factors.

  1993cited by this paper
• A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy

  1993cited by this paper
• Oral anticoagulant drugs.

  1991cited by this paper
• Therapeutic control of oral anticoagulant treatment in The Netherlands.

  1988cited by this paper
• Laboratory control, optimal therapeutic ranges and therapeutic quality control in oral anticoagulation.

  1985cited by this paper
• Therapeutic control of anticoagulant treatment.

  1982cited by this paper

• Retrospective cohort study for evaluating the INR monitoring patterns in patients with deep vein thrombosis in daily practice: Analysis of 2010–2013 database of a tertiary care center

  2018cites this paper
• Quality control of oral anticoagulation with vitamin K antagonists in primary care patients in Poland: a multi-centre study.

  2018cites this paper
• UvA-DARE ( Digital Academic Repository ) Treatment with vitamin K antagonists : patients ' quality of life , valuations and adherence

  2017cites this paper
• Optimization of monitoring and management of anticoagulant therapy

  2017cites this paper
• Outcomes of a Pharmacist Managed Anticoagulation Service

  2016cites this paper
• Control of anticoagulation with vitamin K antagonists: overestimation of median time in therapeutic range when assessed by linear interpolation

  2016cites this paper
• Is the time in therapeutic range using the ratio of tests equivalent to the Rosendaal method?

  2015cites this paper
• The role of primary and secondary care in the management of pulmonary embolism : A shifting paradigm? Developments in diagnosis and treatment

  2013cites this paper
• Effect of 200μG/day of vitamin K1 on the variability of anticoagulation control in patients on warfarin: a randomized controlled trial.

  2013cites this paper
• Rationale and design of the Clarification of Optimal Anticoagulation through Genetics trial.

  2013cites this paper
• Anticoagulation control quality affects the D-dimer levels of atrial fibrillation patients.

  2012cites this paper
• Phenprocoumon and acenocoumarol treatment in paediatric patients

  2012cites this paper
• Benchmark for Time in Therapeutic Range in Venous Thromboembolism: A Systematic Review and Meta-Analysis

  2012influential citation
• Self-management of oral anticoagulation therapy--methodological and clinical aspects.

  2011cites this paper
• Improvement in the regulation of the vitamin K antagonist acenocoumarol after a standard initial dose regimen: prospective validation of a prescription model

  2009cites this paper
• The relationship between adherence and quality of treatment with vitamin K antagonists

  2009cites this paper
• Changes in surrogate outcomes can be translated into clinical outcomes using a Monte Carlo model.

  2009cites this paper
• Comparative study of accuracy and clinical agreement of the CoaguChek XS portable device versus standard laboratory practice in unexperienced patients

  2009cites this paper
• Measuring quality of oral anticoagulation care: extending quality measurement to a new field.

  2009cites this paper
• The cost‐effectiveness of computer‐assisted anticoagulant dosage: results from the European Action on Anticoagulation (EAA) multicentre study

  2009cites this paper
• The effect of an interactive voice response system on communication of medication and appointment information to patients taking oral anticoagulants

  2008cites this paper
• Practice Guidelines (8th Edition) Chest Physicians Evidence-Based Clinical Vitamin K Antagonists: American College of Pharmacology and Management of the

  2008cites this paper
• Anticoagulation intensity and outcomes among patients prescribed oral anticoagulant therapy: a systematic review and meta-analysis

  2008cites this paper
• Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

  2008cites this paper
• Outpatient management of oral vitamin K antagonist therapy: defining and measuring high-quality management

  2008cites this paper
• A multicentre randomised clinical endpoint study of parma 5 computer‐assisted oral anticoagulant dosage

  2008cites this paper
• Bruk av Marevan® i klinisk praksis Utprøving av ein metode for kartlegging og evaluering av warfarinbehandling

  2007cites this paper
• Anticoagulation Control in the Peri-Hospitalization Period

  2007cites this paper
• The effect of hospitalization on oral anticoagulation control: a population-based study.

  2007cites this paper
• Tværsektorielt samarbejde mellem almen praksis og hospital - shared care belyst ved antikoagulansbehandling som eksempel: - en medicinsk teknologivurdering

  2006cites this paper
• Anticoagulation Control in the Peri-Hospitalization Period

  2006cites this paper
• Effect of study setting on anticoagulation control: a systematic review and metaregression.

  2006cites this paper
• Abnormal left atrial membranous structure in transthoracic echocardiography caused by external compression from a large bronchogenic cyst

  2006cites this paper
• Cardiovascular magnetic resonance of left ventricular pseudoaneurysm

  2005cites this paper
• Eftirlit með blóðþynningarmeðferð á Heilbrigðisstofnun Þingeyinga : gæðastjórnunarverkefni

  2005cites this paper
• Eftirlit með blóðþynningarmeðferð á Heilbrigðisstofnun Þingeyinga - gæðastjórnunarverkefni

  2005cites this paper
• Efficacy of Computer-Aided Dosing of Warfarin Among Patients in a Rehabilitation Hospital

  2005cites this paper
• Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome

  2005cites this paper
• Evaluation of survival and ischaemic and thromboembolic event rates in patients with non-valvar atrial fibrillation in the general population when treated and untreated with warfarin

  2004cites this paper
• Occurrence and quality of anticoagulant treatment of chronic atrial fibrillation in primary health care in Sweden: a retrospective study on electronic patient records

  2004cites this paper
• Anticoagulant treatment of patients with chronic atrial fibrillation in primary health care in Sweden--a retrospective study of incidence and quality in a registered population.

  2004cites this paper
• Self-Management of Oral Anticoagulant Therapy: A Review

  2004cites this paper
• The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

  2004cites this paper
• The relationship between adherence and quality of treatment with vitamin K antagonists

  2004cites this paper
• Treatment with vitamin K antagonists: patients'quality of life, valuations and adherence

  2004influential citation
• A Prospective Controlled Study of a Computer-Assisted Acenocoumarol Dosage Program

  2003cites this paper
• Quality Assessment of Anticoagulation Dose Management: Comparative Evaluation of Measures of Time-in-Therapeutic Range

  2003cites this paper
• Age and First INR After Initiation of Oral Anticoagulant Therapy with Acenocoumarol Predict the Maintenance Dosage

  2003cites this paper
• The quality of routine oral anticoagulant therapy in a large geographical area. A survey of 310,300 inhabitants.

  2002cites this paper
• Prospective evaluation of the quality of oral anticoagulation management in an outpatient clinic and in general practices.

  2002cites this paper
• A randomized controlled trial of shared care versus routine care for patients receiving oral anticoagulant therapy

  2002cites this paper
• Low-intensity warfarin is ineffective for the prevention of PTFE graft failure in patients on hemodialysis: a randomized controlled trial.

  2002cites this paper
• Computerized management of oral anticoagulant therapy: experience in major joint arthroplasty.

  2002cites this paper
• Managing oral anticoagulant therapy.

  2001cites this paper
• Factors influencing the frequency of attendance at a warfarin dosing clinic.

  2001cites this paper
• Improving Methods to Assess Therapeutic Quality Control of Treatment with Oral Anticoagulants

  2000cites this paper
• Advances in Therapy and the Management of Antithrombotic Drugs for Venous Thromboembolism.

  2000cites this paper